Analysis of Cardio Diagnostics Holdings Inc. (CDIO)
Cardio Diagnostics Holdings Inc. (CDIO) has shown some interesting price movements and technical indicators in the recent days:
1. Price Movement:
- The stock price closed at $1.93, showing an upward trend from the previous day's open of $1.87.
- The price ranged from a low of $1.83 to a high of $1.94, indicating some volatility in the market.
2. Technical Indicators:
- Relative Strength Index (RSI) is at 81.16, suggesting that the stock may be overbought and a potential reversal could be on the horizon.
- Moving Average Convergence Divergence (MACD) is positive at 0.0295, with the MACD line crossing above the signal line, indicating a bullish signal.
- The Moving Average (MA) indicator is at 0.793, which is below the current price, suggesting a potential uptrend.
Overall, based on the technical indicators, CDIO seems to be in a bullish phase with the MACD and MA indicators showing positive signals. However, the high RSI value indicates a potential overbought situation, so investors should exercise caution and monitor the stock closely for any signs of a reversal.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant cash outflows, mainly due to common stock repurchases and dividend payments.
6. Investing activities have also seen significant cash flows, with the company making investments and acquisitions while also divesting assets.
7. Overall, the company seems to be managing its cash flows effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:
1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Year Ago EPS: $1.26
- Number of Analysts: 26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Year Ago EPS: $1.46
- Number of Analysts: 25
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Year Ago EPS: $6.13
- Number of Analysts: 39
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Year Ago EPS: $6.59
- Number of Analysts: 39
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two years. The average estimates are showing growth compared to the year-ago EPS figures, indicating optimism among analysts regarding the company's performance.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with a slightly higher growth rate expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest that the company has experienced significant growth in the past but is expected to see a more moderate growth rate in the coming years. The next year is expected to show a higher growth rate compared to the current year, but still lower than the average growth rate of the past 5 years.
Price target
The analysts' forecast for the future price of the security paper is as follows:
- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion, total debt of $104.59 billion, and a current ratio of 1.037. The profit margin is 26.31%, with a return on assets of 22.07% and return on equity of 147.25%. The fiscal year ends on September 30, 2023.
In terms of income statement, the company has an EBITDA of $131.39 billion, revenue of $381.62 billion, and a net income to common of $100.39 billion. The most recent quarter ended on March 31, 2024, with a revenue per share of $24.54 and diluted EPS of $6.44. The quarterly revenue and earnings growth rates are negative at -4.3% and -2.2% respectively.
The stock statistics show a short ratio of 1.66, with 94.31 million shares shorted out of 15.31 billion float shares. The stock has an average 10-day volume of 52.90 million and an average 90-day volume of 62.82 million. The stock price summary includes a beta of 1.264, 50-day moving average of $173.69, and 200-day moving average of $180.79. The 52-week low and high prices are $164.08 and $199.62, with a 52-week change of 8.25%.
In terms of valuations metrics, the company has a PEG ratio of 26.21, forward P/E of 26.21, and trailing P/E of 29.43. The enterprise value is $2.95 trillion, with a price to book ratio of 39.18 and price to sales ratio of 7.62. The enterprise to EBITDA ratio is 22.75 and enterprise to revenue ratio is 7.73. The market capitalization stands at $2.91 trillion.
Lastly, the company's dividends and splits information includes a payout ratio of 14.93%, with a forward annual dividend rate of $1 and a trailing annual dividend rate of $0.97. The ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73%, while the forward annual dividend yield is 0.53% and trailing annual dividend yield is 0.51%.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential challenge in managing production or procurement costs.
3. The gross profit margin has remained relatively stable, with gross profit increasing along with sales revenue.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing, reflecting the company's ability to manage expenses and generate profits.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years.
7. The company has been able to maintain a healthy EBITDA margin, indicating efficient operational performance.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and improving over the years.MACD of CDIO